An article recently published in the prestigious
journal Planta Medica 2012 (DOI: hhtp://dx.doi.org/10.1055/s-0031-1298149)
entitled “solasodine rhamnosyl glycosides cause apoptosis in cancer cells, Do
they also prime the immune system resulting in long-term protection against
cancer?” by Cham and Chase describes how the active ingredients in
Curaderm BEC5 programs cancer cell death by a highly organised
process. It was reported that the active
ingredients, in Curaderm BEC5 were more effective as anticancer
agents than many promising newer drugs and older currently much used anticancer
drugs.
The exciting parts of the above article
is that the anticancer active ingredients (BEC) in Curaderm BEC5 not
only cure animals suffering from terminal internal cancers, but these
ingredients have additional effects of also stimulating immunity against the
cancer and causes long term remission.
In a previously published study it was
shown that the active ingredients in Curaderm BEC5 slowed tumour
growth and provided a survival benefit of malignant mesothelioma by stimulation
of the immune system.
The observations are of tremendous
interest and may play a role in the treatment of skin cancers with Curaderm BEC5. These effects, together with the killing of
cancer cells with BEC by a highly organised process, may translate how and why
treatment of skin cancers with Curaderm BEC5 impressively and
astoundingly results in the non comparable cosmetic outcomes.
